Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: Studies on protein, glucose, and lipid metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 9, 2000, Pages 3036-3042

  Mauras, Nelly ^a   Martinez, Victor ^b   Rini, Annie ^a   Guevara Aguirre, Jaime ^b  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b Department of Pediatrics   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCEROL; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; LEUCINE; RECOMBINANT SOMATOMEDIN C;

ADULT; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE METABOLISM; HUMAN; LARON SYNDROME; LEAN BODY WEIGHT; LIPID METABOLISM; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 0033709675     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.9.3036     Document Type: Article

References (38)

1. Metabolic effects of recombinant human insulin-like growth factor I in humans: Comparison with recombinant human growth hormone
2. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome
3. Two year treatment of GH receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency
4. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect
5. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man
6. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
7. Effect of trypsin treatment on rat adipocytes on biological effects and binding of insulin and IGFs: Further evidence for the action of IGFs through the insulin receptor
8. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors
9. rhIGF-I administration in man: Differential sensitivity to the metabolic effects of subcutaneous (SC) bolus vs. continuous delivery
10. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans
11. Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes
12. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorian patients with Laron syndrome
13. Diverse growth hormone gene mutations in Laron syndrome
14. Laron dwarfism and mutations of the GH receptor gene
15. Phenotype: Genotype relationships in growth hormone insensitivity syndrome
16. Normal intelligence with severe IGF-I deficiency due to GH receptor deficiency: A controlled study in a genetically homogeneous population
17. Bone mineral, histomorphometry, and body composition in adults with GH receptor deficiency
18. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient
19. Growth hormone insensitivity syndrome due to primary GH receptor deficiency
20. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency
21. Growth hormone therapy in adults and children
22. IGF-I treatment of adult patients with Laron syndrome
23. Heated dorsal hand vein sampling for metabolic studies: A reappraisal
24. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: Lack of synergy on whole body protein anabolism in normally fed subjects
25. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis
26. Use of t-butyldimethylsilylation in gas chromatographic mass spectrometric analysis of physiologic compounds found in plasma using electron impact ionization
27. 2
28. Use of reciprocal pool specific activities to model leucine metabolism in humans
29. The theoretical bases of indirect calorimetry: A review
30. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
31. IGF-I and GH treatment in GH deficient humans: Differential effects on protein, glucose, lipid and calcium metabolism
32. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength and adiposity
33. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
34. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in post-absorptive men
35. Different effects of IGF-1 on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle
36. Comparison of the effects of GH and IGF-I on substrate oxidation and on insulin sensitivity in GH deficient humans
37. Pharmacokinetics of insulin-like growth factor-1 in hypopituitarism: Correlation with binding proteins
38. Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency